GENEXPERT (XPERT MTB/RIF) - EXTRAPULMONARY

GeneXpert (Xpert MTB/RIF) - Extrapulmonary is an advanced molecular diagnostic test designed for the rapid detection of Mycobacterium tuberculosis (MTB) in extrapulmonary specimens and simultaneous identification of Rifampicin resistance. The test uses automated real-time PCR technology to provide highly accurate results for tuberculosis infections occurring outside the lungs.

Extrapulmonary tuberculosis (EPTB) can affect lymph nodes, pleural fluid, cerebrospinal fluid, bones, joints, abdomen, genitourinary tract, and other organs. Diagnosing EPTB is often challenging because the bacterial load may be low and symptoms may vary depending on the affected organ. GeneXpert offers rapid and reliable molecular detection that supports early diagnosis and treatment.

Benefits of the Test

• Rapid detection of Mycobacterium tuberculosis in extrapulmonary specimens.
• Simultaneously identifies Rifampicin resistance.
• Provides highly sensitive molecular diagnosis.
• Supports early treatment initiation.
• Useful for difficult-to-diagnose extrapulmonary TB cases.
• Reduces diagnostic delays compared to conventional methods.
• Supports management of drug-resistant TB.
• Improves patient care and treatment planning.

Why Doctors Recommend This Test

Doctors recommend GeneXpert MTB/RIF Extrapulmonary testing for patients with suspected tuberculosis affecting organs outside the lungs, including lymph node TB, TB meningitis, pleural TB, abdominal TB, bone and joint TB, genitourinary TB, and other forms of extrapulmonary disease.

The test helps confirm the diagnosis quickly and identifies Rifampicin resistance, allowing appropriate anti-tubercular therapy to be started without unnecessary delay.

Preparation Before Test

• No fasting is generally required.
• The required specimen depends on the suspected site of infection.
• Samples may include lymph node aspirate, cerebrospinal fluid, pleural fluid, pus, tissue biopsy, ascitic fluid, or other clinical specimens.
• Follow all sample collection instructions provided by healthcare professionals.
• Inform your doctor about previous TB treatment history.
• Provide relevant medical records and imaging reports if available.

Normal Reporting Time

Most GeneXpert (Xpert MTB/RIF) - Extrapulmonary reports at Focus Diagnostics are available within 2–3 hours after specimen processing and molecular workflow initiation. Final validated reporting may vary depending on specimen type and laboratory quality assurance procedures.

Who Should Take This Test?

This test may be recommended for:

• Patients with suspected lymph node tuberculosis.
• Individuals with suspected TB meningitis.
• Patients with pleural effusion suspected to be due to TB.
• Individuals with abdominal tuberculosis.
• Patients with bone and joint TB.
• People with genitourinary tuberculosis.
• Immunocompromised individuals with suspected EPTB.
• Patients requiring rapid extrapulmonary TB diagnosis.

Detailed Information

Extrapulmonary tuberculosis refers to tuberculosis infections that occur outside the lungs. Although pulmonary TB is the most common form, TB bacteria can spread through the bloodstream or lymphatic system and affect multiple organs. Symptoms vary significantly depending on the site involved and may include lymph node swelling, persistent fever, headaches, abdominal pain, joint pain, neurological symptoms, or unexplained fluid collections.

Traditional diagnostic methods for extrapulmonary TB often face challenges because specimens may contain very low numbers of bacteria. Smear microscopy frequently yields negative results, while culture methods may require several weeks before confirmation is available. Rapid diagnosis is especially important because delayed treatment can lead to serious complications.

The GeneXpert MTB/RIF assay uses automated real-time Polymerase Chain Reaction (PCR) technology to detect genetic material from Mycobacterium tuberculosis and simultaneously identify mutations associated with Rifampicin resistance. Rifampicin resistance is an important marker of multidrug-resistant tuberculosis and has significant treatment implications.

The test can be performed on a wide variety of extrapulmonary specimens, including cerebrospinal fluid, lymph node aspirates, tissue biopsies, pleural fluid, ascitic fluid, pus, synovial fluid, and other clinically relevant samples. Its high sensitivity and rapid turnaround time make it particularly valuable in diagnosing difficult TB cases.

GeneXpert is widely recommended by tuberculosis control programs and international health organizations because it improves diagnostic accuracy and enables earlier treatment decisions. Rapid identification of drug resistance also helps clinicians choose effective treatment regimens.

Results should always be interpreted together with clinical findings, imaging studies, histopathology, microbiology culture results, and physician evaluation. Additional drug susceptibility testing may be recommended in selected cases.

At Focus Diagnostics, GeneXpert (Xpert MTB/RIF) - Extrapulmonary testing is performed using advanced molecular diagnostic systems, validated PCR technology, and stringent quality assurance standards to provide accurate, reliable, and clinically meaningful tuberculosis diagnostic results.